Blood Pressure-Lowering Therapy

Area of Science:

• Cardiology
• Hypertension Management
• Atherosclerosis Research

Background:

• Elevated blood pressure is a major risk factor for cardiovascular morbidity and mortality.
• Atherosclerotic cardiovascular disease (ASCVD) risk is substantially reduced by blood pressure lowering.
• Arterial hypertension requires comprehensive management strategies.

Purpose of the Study:

• To summarize current recommendations for arterial hypertension management based on the 2018 ESC/ESH Guidelines.
• To review lifestyle interventions, pharmacotherapy, and device-based treatments.
• To highlight antihypertensive drug effects on vascular wall components in atherosclerosis pathogenesis.

Main Methods:

• Literature review and synthesis of the 2018 European Society of Cardiology/European Society of Hypertension Joint Guidelines.
• Focus on evidence supporting blood pressure reduction for cardiovascular risk mitigation.
• Analysis of direct vascular effects of antihypertensive agents.

Main Results:

• Blood pressure lowering is a cornerstone of ASCVD risk reduction.
• Current guidelines emphasize a multi-faceted approach to hypertension management.
• Certain antihypertensive drugs possess direct vascular protective effects relevant to atherosclerosis.

Conclusions:

• Effective hypertension management is crucial for preventing atherosclerotic cardiovascular disease and death.
• Adherence to updated guidelines ensures optimal patient care.
• Targeting vascular wall mechanisms offers novel therapeutic avenues in hypertension and atherosclerosis.